TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17093249

Group type: EXPERIMENTAL
Intervention: Neurostimulation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Neurostimulation (after 6 months of active treatment)
Number of subjects: 40
Study: 15243006

Group type: EXPERIMENTAL
Intervention: FF-MAS 5 microM
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: FF-MAS 20 microM
Number of subjects: 243

Group type: COMPARATOR
Intervention: Ethanol 0.2% (vehicle control)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Water for injection (inert control)
Number of subjects: 243
Study: 12821971

Group type: EXPERIMENTAL
Intervention: 1.8 g CLA per day (low dosage, LD)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 3.6 g CLA per day (high dosage, HD)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo LD
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo HD
Number of subjects: 54
Study: 10225800

Group type: EXPERIMENTAL
Intervention: Neoprene sleeve
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Unloader brace
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 119
Study: 7782190

Group type: EXPERIMENTAL
Intervention: Gd-DOTA
Number of subjects: 1038

Group type: COMPARATOR
Intervention: Gd-DTPA
Number of subjects: 1038
Study: 1976680

Group type: EXPERIMENTAL
Intervention: Sequential use of unmedicated soap (3 min) followed by 'Hibisol' (4 min)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of 'Hibiscrub' (3 min) and 'Hibisol' (4 min)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of 'Hibisol' for 5 min
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference procedure with 60% n‐propanol (5 min)
Number of subjects: 0
Study: 639614

Group type: EXPERIMENTAL
Intervention: Anal dilatation
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sphincterotomy
Number of subjects: 66
Study: 31164158

Group type: EXPERIMENTAL
Intervention: Education and self-management group behavioural intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fidelity assessment through audio recordings
Number of subjects: 0
Study: 29048969

Group type: EXPERIMENTAL
Intervention: Adolescent Depression Awareness Program (ADAP; n=3681)
Number of subjects: 6679

Group type: COMPARATOR
Intervention: Waitlist control condition (n=2998)
Number of subjects: 6679
Study: 26992237

Group type: EXPERIMENTAL
Intervention: 25% caloric restriction (CR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ad-Libitum intake (AL)
Number of subjects: 0
Study: 25141241

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg once daily
Number of subjects: 651

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 651
Study: 22542608

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 deficiency assessment via Functional Intracellular Assay (FIA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (age- and gender-matched)
Number of subjects: 22
Study: 19091408

Group type: EXPERIMENTAL
Intervention: Phase III RCTs
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Bevacizumab interventional case studies
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Bevacizumab studies
Number of subjects: 36
Study: 17468463

Group type: EXPERIMENTAL
Intervention: TBI education
Number of subjects: 30164

Group type: EXPERIMENTAL
Intervention: TBI education (for those visiting Nantucket Island for more than 2 weeks)
Number of subjects: 30164

Group type: COMPARATOR
Intervention: Bicycle safety education
Number of subjects: 30164
Study: 15249406

Group type: EXPERIMENTAL
Intervention: Warmed, humidified CO2 insufflation (group B)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard CO2 insufflation (group A)
Number of subjects: 101
Study: 12028405

Group type: EXPERIMENTAL
Intervention: Lamivudine 150 mg daily for four weeks
Number of subjects: 0
Study: 9820260

Group type: EXPERIMENTAL
Intervention: Individualized Chinese herbal formulations (n = 38)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Standard Chinese herbal formulation (n = 43)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo (n = 35)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both active treatment groups (individualized and standard CHM)
Number of subjects: 116
Study: 7715792

Group type: EXPERIMENTAL
Intervention: Pergolide
Number of subjects: 400
Study: 29188483

Group type: EXPERIMENTAL
Intervention: Re-irradiation treatment schedules
Number of subjects: 375
Study: 26873702

Group type: EXPERIMENTAL
Intervention: Combination of BRAF inhibitor dabrafenib and MEK inhibitor trametinib
Number of subjects: 1

Group type: COMPARATOR
Intervention: Monotherapy with dabrafenib (plus placebo)
Number of subjects: 1
Study: 24744318

Group type: EXPERIMENTAL
Intervention: Double-fortified salt (DFS) with 3.3 mg ferrous fumarate (1.1 mg elemental iron) per kg of iodized salt for 7.5 to 9 months
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control iodized salt (47 mg/kg potassium iodate) for 7.5 to 9 months
Number of subjects: 212
Study: 23677749

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation treatment consisting of 16 one-hour individual sessions of therapist-guided cognitive training over 4 weeks, combining computer exercises and metacognitive training.
Number of subjects: 109

Group type: COMPARATOR
Intervention: Usual care without cognitive training (Control group).
Number of subjects: 109
Study: 20033244

Group type: EXPERIMENTAL
Intervention: Chewable tablet containing calcium and vitamin D (Calci Chew D(3), Nycomed)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Sachet containing calcium and vitamin D(3) (Cad, Will‐Pharma)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: No preference
Number of subjects: 102
Study: 18256175

Group type: EXPERIMENTAL
Intervention: Grazax (ALK‐Abelló) for sublingual immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intranasal corticosteroids and oral antihistamines
Number of subjects: 0
Study: 16527695

Group type: EXPERIMENTAL
Intervention: Nitazoxanide tablets (500 mg, twice daily for 3 days)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nitazoxanide oral suspension (500 mg, twice daily for 3 days)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (matching tablet, twice daily for 3 days)
Number of subjects: 90
Study: 14505071

Group type: EXPERIMENTAL
Intervention: Z250
Number of subjects: 150

Group type: COMPARATOR
Intervention: Z100
Number of subjects: 150
Study: 10743981

Group type: EXPERIMENTAL
Intervention: Humalog Mix75/25
Number of subjects: 84

Group type: COMPARATOR
Intervention: Human insulin 70/30
Number of subjects: 84
Study: 8755321

Group type: EXPERIMENTAL
Intervention: Oral human recombinant epidermal growth factor (450 mg/day)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Oral human recombinant epidermal growth factor (600 mg/day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 75
Study: 1407989

Group type: EXPERIMENTAL
Intervention: Levamisole alone (150 mg/day for 3 consecutive days)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Levamisole in combination with prednisone (150 mg/day for 3 consecutive days)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Levamisole (alone or in combination with prednisone)
Number of subjects: 39
Study: 4008417

Group type: EXPERIMENTAL
Intervention: Cigarette smoking (3 cigarettes/h for 5 h)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (no smoking)
Number of subjects: 9
Study: 29100198

Group type: EXPERIMENTAL
Intervention: sucking + breast milk
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: sucking + breast milk + tucking
Number of subjects: 109

Group type: COMPARATOR
Intervention: routine care
Number of subjects: 109
Study: 28414474

Group type: EXPERIMENTAL
Intervention: Abstinence Incentives plus weekly behavioral parent training (EXP)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Attendance Incentives (CONTROL)
Number of subjects: 75
Study: 26122834

Group type: EXPERIMENTAL
Intervention: pUDK-HGF (4-16 mg)
Number of subjects: 21
Study: 23851746

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (blood clot)
Number of subjects: 20
Study: 20864308

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study: 18230858

Group type: EXPERIMENTAL
Intervention: Fast ForWord Language (FFW‐L)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Computer‐assisted language intervention (CALI)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Individualized language intervention (ILI)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Academic enrichment (AE)
Number of subjects: 216

Group type: COMPARATOR
Intervention: All conditions (FFW‐L, AE, CALI, ILI)
Number of subjects: 216
Study: 15692611

Group type: EXPERIMENTAL
Intervention: Eyetrack
Number of subjects: 20

Group type: COMPARATOR
Intervention: CPR
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Eyetrack (expert user)
Number of subjects: 20
Study: 12949382

Group type: EXPERIMENTAL
Intervention: Tea intake (mean daily intake 525 mL)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: 4-O-methylgallic acid excretion (biomarker of tea-derived polyphenols)
Number of subjects: 218
Study: 10958582

Group type: EXPERIMENTAL
Intervention: Whole body shots in colour or monochrome (Expt 1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Close-up pictures of targets' faces (Expt 2)
Number of subjects: 80
Study: 9275324

Group type: EXPERIMENTAL
Intervention: Respiratory strengthening training programs
Number of subjects: 24

Group type: COMPARATOR
Intervention: Routine physical exercises (Control)
Number of subjects: 24
Study: 1892491

Group type: EXPERIMENTAL
Intervention: Cholestyramine taken with food
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cholestyramine taken before food
Number of subjects: 10
Study: 6441716

Group type: EXPERIMENTAL
Intervention: Oral potassium supplementation during protein-modified fast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Protein-modified fast without potassium supplementation
Number of subjects: 0
Study: 31151820

Group type: EXPERIMENTAL
Intervention: Individual nutritional assessment
Number of subjects: 170

Group type: COMPARATOR
Intervention: Standardized enteral nutrition
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 170
Study: 28414493

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 126
Study: 26607845

Group type: EXPERIMENTAL
Intervention: Erythropoiesis-stimulating agent (ESA; darbepoetin-α) treatment
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both ESA treatment and endurance training
Number of subjects: 35
Study: 24739510

Group type: COMPARATOR
Intervention: DynaClose tissue expansion tapes applied across the forearm one week pre-operatively.
Number of subjects: 24
Study: 23149692

Group type: EXPERIMENTAL
Intervention: Webcams with a central monitoring system and virtual bed rail function for patients with a Morse Risk Assessment (MRA) score greater than 25.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no Webcams).
Number of subjects: 10
Study: 20613670

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day for 6 months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no medications)
Number of subjects: 70
Study: 18167048

Group type: EXPERIMENTAL
Intervention: Sugar cane policosanol 20 mg daily for 8 weeks
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 16359632

Group type: EXPERIMENTAL
Intervention: High cross-modal dissimilarity textures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low cross-modal dissimilarity textures
Number of subjects: 0
Study: 15320669

Group type: EXPERIMENTAL
Intervention: Caffeine (7 mg.kg(‐1) of body weight)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (vitamin C, same dosage as caffeine)
Number of subjects: 10
Study: 11207403

Group type: EXPERIMENTAL
Intervention: 2-min infusion of prochlorperazine (10 mg) followed by a 15-min infusion of saline
Number of subjects: 160

Group type: COMPARATOR
Intervention: 15-min infusion of prochlorperazine (10 mg) following a 2-min infusion of saline
Number of subjects: 160
Study: 9308800

Group type: EXPERIMENTAL
Intervention: Naltrexone alone or naltrexone in combination with an anti-oestrogen
Number of subjects: 22

Group type: COMPARATOR
Intervention: Gonadotrophin induction of ovulation
Number of subjects: 22
Study: 8233386

Group type: EXPERIMENTAL
Intervention: Mitomycin 0.2 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Mitomycin 0.02 mg
Number of subjects: 11
Study: 3658353

Group type: COMPARATOR
Intervention: Aqueous phenylephrine hydrochloride (2.5%) in 32 microliters drop volume
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 10% aqueous phenylephrine in 8 microliters drop volume
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both preparations (2.5% in 32 microliters and 10% in 8 microliters)
Number of subjects: 10
Study: 30337343

Group type: EXPERIMENTAL
Intervention: Walk by Faith (WbF) - monthly diet and exercise education sessions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Walk by Faith (WbF) - men
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Walk by Faith (WbF) - married women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Walk by Faith (WbF) - unmarried women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Walk by Faith (WbF) - participation level
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ribbons of Faith (RoF) - educational program
Number of subjects: 0
Study: 27188744

Group type: EXPERIMENTAL
Intervention: HIFU once
Number of subjects: 123

Group type: COMPARATOR
Intervention: halcinonide for 3 months
Number of subjects: 123
Study: 25300977

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 22614993

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention
Number of subjects: 472

Group type: COMPARATOR
Intervention: Printed educational information
Number of subjects: 472
Study: 20980648

Group type: COMPARATOR
Intervention: 25% milk RUTF
Number of subjects: 1874

Group type: EXPERIMENTAL
Intervention: 10% milk RUTF
Number of subjects: 1874
Study: 18600190

Group type: EXPERIMENTAL
Intervention: MMRV vaccine (Priorix-Tetra; GlaxoSmithKline Biologicals) - 2 doses administered 42 days apart (MMRV group; N = 732)
Number of subjects: 970

Group type: COMPARATOR
Intervention: MMR vaccine (Priorix) coadministered with varicella vaccine (Varilrix) - 1 dose followed by a second dose of MMR vaccine 42 days later (MMR + V group; N = 238)
Number of subjects: 970
Study: 16204741

Group type: EXPERIMENTAL
Intervention: StarClose Vascular Closure System
Number of subjects: 208

Group type: COMPARATOR
Intervention: Manual compression
Number of subjects: 208
Study: 12084751

Group type: EXPERIMENTAL
Intervention: Leaflet group (written educational material)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no written information)
Number of subjects: 0
Study: 10596687

Group type: EXPERIMENTAL
Intervention: 800 microg budesonide + 24 microg formoterol (Bud800+F)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: 200 microg budesonide + 24 microg formoterol (Bud200+F)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: 1,600 microg budesonide (run-in phase)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: 800 microg budesonide + placebo
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: 200 microg budesonide + placebo
Number of subjects: 470
Study: 8706453

Group type: EXPERIMENTAL
Intervention: Biphasic positive airway pressure ventilation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Volume-controlled mechanical ventilation
Number of subjects: 20
Study: 1721219

Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 16
Study: 6214437

Group type: EXPERIMENTAL
Intervention: Oral treatment with tetracycline (total dose: 1st month 28.5 g; 2nd and 3rd months 15.0 g)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 30476254

Group type: EXPERIMENTAL
Intervention: Reducing calcineurin inhibitor (CNI first)
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Reduction of mycophenolic acid
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Tacrolimus reduction
Number of subjects: 644
Study: 28597604

Group type: EXPERIMENTAL
Intervention: Lesinurad 400 mg daily plus febuxostat 80 mg/day
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Lesinurad 200 mg daily plus febuxostat 80 mg/day
Number of subjects: 324

Group type: COMPARATOR
Intervention: Febuxostat 80 mg/day alone
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Lesinurad 200 mg and 400 mg plus febuxostat
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Lesinurad 400 mg
Number of subjects: 324
Study: 26264630

Group type: EXPERIMENTAL
Intervention: Acemannan
Number of subjects: 42

Group type: COMPARATOR
Intervention: Calcium hydroxide
Number of subjects: 42
Study: 25846114

Group type: EXPERIMENTAL
Intervention: NO3 (‐)‐rich beetroot juice (BR; 140 mL day(‐1); 12.8 mmol of NO3 (‐))
Number of subjects: 16

Group type: COMPARATOR
Intervention: NO3 (‐)‐depleted beetroot juice (PL; 140 mL day(‐1); 0.08 mmol NO3 (‐))
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: NO3 (‐)‐rich beetroot juice (BR)
Number of subjects: 16

Group type: COMPARATOR
Intervention: NO3 (‐)‐depleted beetroot juice (PL)
Number of subjects: 16
Study: 22628590

Group type: EXPERIMENTAL
Intervention: Hip Resurfacing Arthroplasty (HRA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Total Hip Replacement (THR)
Number of subjects: 80
Study: 19812931

Group type: EXPERIMENTAL
Intervention: Programmable valve with gravitational unit (proGAV, Aesculap/Miethke, Germany)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional programmable valve (Medos-Codman, Johnson & Johnson, Germany)
Number of subjects: 200
Study: 18593864

Group type: EXPERIMENTAL
Intervention: Alcohol use among Swedish freshmen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol use among Swedish residence hall students
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drinking behavior among US students
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Harmful drinking scores for women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Harmful drinking scores for men
Number of subjects: 0
Study: 16515225

Group type: EXPERIMENTAL
Intervention: Low intensity arm exercises with weights and compression sleeve
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Low intensity arm exercises with weights without compression sleeve
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Low intensity arm exercises with weights with compression sleeve
Number of subjects: 31
Study: 11845652

Group type: EXPERIMENTAL
Intervention: Maternal coordination training; specific intervention to increase maternal coordination with child behavior.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition; no training provided to mothers.
Number of subjects: 0
Study: 10078674

Group type: EXPERIMENTAL
Intervention: Sufentanil (10 microg) + Transdermal Nitroglycerine (5 mg/day)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Sufentanil (10 microg) + Transdermal Placebo
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Transdermal Nitroglycerine (5 mg/day) + Spinal Saline
Number of subjects: 56

Group type: COMPARATOR
Intervention: Spinal Saline + Transdermal Placebo
Number of subjects: 56
Study: 8834664

Group type: EXPERIMENTAL
Intervention: Dihydroxyaluminium-sodium carbonate (Alugastrin)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Aluminium and magnesium hydroxides (Alumag)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study: 2327768

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 102

Group type: COMPARATOR
Intervention: Co-trimoxazole
Number of subjects: 102
Study: 6192774

Group type: EXPERIMENTAL
Intervention: Field diagnosis using a miniature McArthur microscope
Number of subjects: 129

Group type: COMPARATOR
Intervention: Malaria laboratory diagnosis
Number of subjects: 129

Group type: COMPARATOR
Intervention: Diagnosis at an English hospital
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Field's stain for thick films
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Field's stain for thin films
Number of subjects: 129
Study: 31815677

Group type: EXPERIMENTAL
Intervention: App interactive management group (group C)
Number of subjects: 276

Group type: COMPARATOR
Intervention: App self-management group (group B)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Control group (group A)
Number of subjects: 276
Study: 29470151

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 9
Study: 27342500

Group type: EXPERIMENTAL
Intervention: Aidi+R-CHOP
Number of subjects: 51
Study: 24842179

Group type: EXPERIMENTAL
Intervention: BoNT‐A injection (second dose)
Number of subjects: 114
Study: 22779217

Group type: EXPERIMENTAL
Intervention: SRP combined with 1.7% hydrogen peroxide gel (Perio Gel) using custom trays
Number of subjects: 30

Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 30
Study: 19756479

Group type: EXPERIMENTAL
Intervention: Predetermined contact frequency with the study team
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endpoint insulin dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical contact frequency
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telephone contact frequency
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: End-of-study insulin dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contact frequency in DPP-4 inhibitor trials
Number of subjects: 0
Study: 20821332

Group type: EXPERIMENTAL
Intervention: Local intraarterial fibrinolysis (LIF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative standard treatment (CST)
Number of subjects: 0
Study: 16119485

Group type: COMPARATOR
Intervention: PCEA alone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: PCEA + CEI (continuous epidural infusion of ropivacaine 0.15% with sufentanil 0.75 microg/ml at 2 ml/h)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: PCEA + CEI
Number of subjects: 80
Study: 12377832

Group type: EXPERIMENTAL
Intervention: Nasal CPAP treatment for 3 weeks in patients with SDB (AHI >= 5)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nasal CPAP treatment for 3 weeks in patients without SDB (AHI < 5)
Number of subjects: 24